Neoadjuvant treatment with Bevacizumab and folfox-6 in patients with liver metastasis from colorectal cancer: Preliminary results of a phase II study

被引：0
|
作者：
Bertolini, F. [1 ]
Malavasi, N. [1 ]
Dealis, C. [1 ]
Zroni, S. [1 ]
Depenni, R. [1 ]
Fontana, A. [1 ]
Sternieri, R. [1 ]
Ponti, G. [1 ]
Luppi, G. [1 ]
Conte, P. [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Modena, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] A prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver metastasis
    Ji, Jun Ho
    Park, Young Suk
    Lee, Jeeyun
    Kim, Tae Won
    Hong, Yong Sang
    Kim, Kyu-Pyo
    Kim, Sun Young
    Baek, Ji Yeon
    Kang, Hye Jin
    Shin, Sang Joon
    Shim, Byoung Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Phase II trial of FOLFOX6 plus Bevacizumab for patients with unresectable liver and only hepatic metastasis from colorectal cancer: A first preliminary analysis of the safety
    Depenni, R.
    Dealis, C.
    Perrone, S.
    Losi, L.
    Bertolini, F.
    Malavasi, N.
    Zironi, S.
    Luppi, G.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI46 - XI46
  • [3] Phase II trial of imatinib, bevacizumab and cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer
    Sobrero, A. F.
    Bennicelli, E.
    Pessino, A.
    Guglielmi, A.
    Mammoliti, S.
    Caprioni, F.
    Fornarini, G.
    Comandini, D.
    Sciallero, S.
    Ansaldi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis
    Jun Ho Ji
    Se Hoon Park
    Jeeyun Lee
    Tae Won Kim
    Yong Sang Hong
    Kyu-pyo Kim
    Sun Young Kim
    Ji Yeon Baek
    Hye Jin Kang
    Sang Joon Shin
    Byoung Yong Shim
    Young Suk Park
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 223 - 230
  • [5] Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis
    Ji, Jun Ho
    Park, Se Hoon
    Lee, Jeeyun
    Kim, Tae Won
    Hong, Yong Sang
    Kim, Kyu-pyo
    Kim, Sun Young
    Baek, Ji Yeon
    Kang, Hye Jin
    Shin, Sang Joon
    Shim, Byoung Yong
    Park, Young Suk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 223 - 230
  • [6] Bevacizumab plus FOLFOX7 as first line treatment for patients (pts) with metastatic colorectal cancer: Preliminary results of a phase II study
    Oukkal, M.
    Salmi, K.
    Abed-Benmelha, N.
    Sefiane, S.
    Djeddi, H.
    Mahfouf, H.
    Bouzid, K.
    ANNALS OF ONCOLOGY, 2007, 18 : VII84 - VII84
  • [7] Updated results of a phase II study of neoadjuvant chemotherapy with mFOLFOX6+bevacizumab for the synchronous liver metastases from colorectal cancer
    Nakagawa, K.
    Katayose, Y.
    Yamamoto, K.
    Yamauchi, J.
    Oikawa, M.
    Shimamura, H.
    Takahashi, K.
    Miura, K.
    Motoi, F.
    Unno, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S555 - S555
  • [8] NEOADJUVANT BEVACIZUMAB TREATMENT FOR COLORECTAL LIVER METASTASIS: A RETROSPECTIVE STUDY
    Garcia Alfonso, Pilar
    Alvarez, Sonsoles
    Mutnoz, Andres
    Lopez, Pilar
    Riesco, Carmen
    Adeva Alfonso, Jorge
    Martin, Miguel
    ANNALS OF ONCOLOGY, 2011, 22 : v102 - v102
  • [9] Phase II trial of FOLFOX6, bevacizumab and cetuximab in patients with Colorectal Cancer
    Ocean, A. J.
    O'Brien, K.
    Lee, J.
    Matthews, N.
    Holloway, S.
    Christos, P.
    Kung, T. S.
    Kaubisch, A.
    Chen, H.
    Wadler, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] FOLFOX-6 PLUS IMATINIB, BEVACIZUMAB AND CETUXIMAB IN ADVANCED UNTREATED COLORECTAL CANCER
    Andretta, V
    Bennicelli, E.
    Pessino, A.
    Caprioni, F.
    Decian, F.
    Di Benedetto, M.
    Sobrero, A.
    ANNALS OF ONCOLOGY, 2009, 20 : 113 - 113
12345